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Abstract - Injury and other pathological conditions induce a massive release of ATP and ADP that initiate an immune 
response. Extracellular nucleotides are degraded by ectonucleotidases: enzymes from E-NTPDase and E-NPP families 
sequentially hydrolyze ATP and ADP to AMP, which is further hydrolyzed by ecto-5’-nucleotidase to adenosine that exerts 
suppressive effects on immune cells. We investigated the ectonucleotidase activities of peripheral lymphocytes at different 
post-injury times after an unilateral brain injury in the rat. Significant and dynamic changes in the lymphocytic ecto-
nucleotidase activities were obtained. ATP- and ADP-hydrolysis changes, together with their calculated ratios, indicate the 
major contribution of E-NTPDase 1 and its comparable upregulation between sham operation and injury. AMP hydrolysis 
changes were more brain-injury specific, with a longer-lasting lymphocytic response induced by cortical stab injury (CSI). 
In summary, CSI and sham operation induce the upregulation of the whole enzyme chain for adenine nucleotide hydroly-
sis in lymphocytes, suggesting an important roles of ectonucleotidases in the course of recovery after brain injury. 
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INTRODUCTION
In the extracellular compartment, purine di- and tri-
nucleotides act as paracrine molecules that regulate 
the immune response (Di Virgilio, 2005; Bours et 
al., 2006), platelet aggregation and thrombus forma-
tion (Marcus et al., 2003), neurotransmission and 
muscle contraction (Burnstock, 2007), heart rate 
(Vassort, 2001) and many other processes. Physi-
ological concentrations of extracellular nucleotides 
are usually in the nanomolar range (Yegutkin et al., 
2006), whilst injury and other pathological condi-
tions, such as inflammation, hypoxia and ischemia, 
induce the massive release of ATP and ADP from 
damaged and stressed cells into the extracellular 
space (Bodin and Burnstock, 1998; Lazarowski et 
al., 2003). In high concentration, ATP and ADP act 
as tissue-derived distress signals called damage-as-
sociated molecular patterns (DAMPs) (Seong and 
Matzinger, 2004) that initiate immune responses 
(La Sala et al., 2003).          
Extracellular nucleotides exert their effects 
through multiple P2X and P2Y receptors (Ralevic 
and Burnstock, 1998; Abbracchio et al., 2006) which 
are widely expressed at immune and non-immune 
cells (Bours et al., 2011). One of the most studied 
member of the P2 receptor family is the P2X7 re-
ceptor which is apparently involved in sensing dan-
ger (Solle et al., 2001). Activation of P2X7 enhances 
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lymphocytic adhesion and extravasation (Salmi 
and Jalkanen, 2005) and induces the production of 
proinflammatory cytokines such as IL-1β, TNF-α, 
IL-12, IL-18, triggering inflammatory response 
(Bours et al., 2006). 
Extracellular nucleotides are efficiently degrad-
ed by the action of ectonucleotidases (Zimmer-
mann, 2000), widely expressed at various immune 
and non-immune cells, but also present in a soluble 
form in the extracellular compartment (Yegutkin et 
al., 2003). Ectonucleotidases belong to four enzyme 
families: ectonucleoside triphosphate-diphosphohy-
drolases (E-NTPDase), nucleotide pyrophosphatase/
phosphodiesterases (E-NPP), alkaline phosphatase 
(AP) and ecto-5’-nucleotidase (E-5NT) (Lazarowski 
et al., 2000; Yegutkin, 2008). Four of 8 members of 
the E-NTPDase family – E-NTPDases 1, 2, 3 and 8 
– are genuine ectoenzymes (Robson et al., 2006) that 
hydrolyze nucleotides in the range of concentrations 
that activate P2 receptors, with different ratios regard-
ing the hydrolysis of tri- and dinucleosides (Kukulski 
et al., 2005). Enzymes that belong to the E-NTPDase 
and E-NPP families sequentially hydrolyze ATP and 
ADP to AMP, which is further hydrolyzed to adenos-
ine by the action of E-5NT (Zimmermann, 2001). 
Adenosine generated in ectonucleotidasic cas-
cade acts as a negative feedback signal counteract-
ing ATP-mediated stimulation by inhibiting proin-
flammatory cytokine release and promoting IL-10 
production (Bours et al., 2006). Adenosine exerts 
its effect through its own P1 receptor family, ubiqui-
tously present on myeloid and lymphoid cells (Hasko 
and Cronstein, 2004). Studies with knockout models 
revealed that the A2A adenosine receptor may have 
the most important role in downregulation of cell-
mediated immunity (Ohta and Sitkovsky, 2001; Thiel 
et al., 2003; Sitkovsky et al., 2004), by suppressing the 
proliferation and effector functions of lymphocytes.
In the immune system (Bours et al., 2006), as 
well as in the vascular compartment (Marcus et al., 
2003), E-NTPDase1 (EC 3.6.1.5., CD39) and E-5NT 
(EC 3.1.3.5., CD73) are designated as key regula-
tors of purinergic signalization. It was demonstrated 
(Dombrowski et al. 1995; 1998) that E-NTPDase1 
mediates cell adhesion and antigen recognition, as 
well as the cytokine secretion and cytolytic activity 
of T-cells, whilst for E-5NT, Airas et al., (1998; 2000) 
showed that it contributes to lymphocytic prolifera-
tion and activation, and promotes lymphocytic bind-
ing to endothelial vascular cells, enabling extravasa-
tion. These findings were supported by the results of 
experiments with animals deficient in genes for both 
enzymes (Sun et al., 2011; Mills et al., 2008). 
Several neuropathologies, including brain in-
jury, are now considered to be true neuroinflam-
matory conditions (Morganti-Kossman et al., 2007) 
owing to their sustained microglial and astroglial 
activation (Di Virgilio et al., 2009), disruption of the 
blood brain barrier and entry of lymphocytes from 
the periphery (Soares et al., 1995; Wang and Dore, 
2007). Nevertheless, the results from several groups 
have shown that various insults to the brain, such 
as epilepsy (Bruno et al., 2003; Busnello et al., 2008; 
Grosso et al., 2009) or experimental autoimmune en-
cephalomyelitis (Lavrnja et al., 2009), induce chang-
es in ectonucleotidase activities in the serum. On the 
other hand, studies with knockout animals that lack 
the genes for E-NTPDase 1 (Sun et al., 2011; Hyman 
et al., 2009), or E-5NT (Mills et al., 2008; Thompson 
et al., 2008; Takedachi et al., 2008), confirmed that 
their coordinated activity is essential for an adequate 
immune response in the inflammatory, hypoxic and 
prothrombotic states that arise as a consequence of 
brain injury (Jeremitsky et al., 2003). Considering 
the role of ectonucleotidases in the control of lym-
phocyte effector functions (Yegutkin et al., 2010; 
Bours et al., 2006), in this study we have examined 
ectonucleotidase activities in the isolated fraction of 
peripheral lymphocytes at different post-injury times 
after unilateral brain injury in rats.
MATERIALS AND METHODS
Animals
Adult male Wistar rats (55 animals, 3 months old, 
250-300 g body weight) were used in this study. The 
animals were maintained three to a cage at a constant 
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temperature on a 12 h light/dark cycle with free ac-
cess to food and water. 
Surgical procedure
The experimental protocols were approved by the 
Institutional Animal Care Committee and were in 
conformity with the recommendation provided by 
the European Convention for the Protection of Ver-
tebrate Animals used for Experimental and Other 
Scientific Purposes (ETS no. 123, Appendix A). All 
efforts were made to minimize the number of used 
animals and their suffering.
Fifty animals were randomly divided into two 
groups. Each animal was anesthetized with an intra-
peritoneal injection of Zoletil®50 (Virbac, France) in 
a dose of 50 mg/kg body weight; they were positioned 
into a stereotaxic frame and the scalp was shaved. An 
incision was made along the midline of the scalp and 
the bregma was exposed. Cortical stab injury (CSI) 
was performed as previously described (Nedeljković 
et al. 2006) by a 1 mm-wide dental drill through the 
skull on the left side (2 mm lateral from the midline, 
2 mm posterior to the bregma). The drill was insert-
ed 1.5 mm below the underlying cortical region. The 
wound was sterile-closed. Animals in another group 
were anesthetized, the scalps were shaved and after 
making the incision along the midline leaving the 
dura intact, the wound was sutured (sham-operated 
animals). Animals were placed in a heated room and 
monitored while recovering from anesthesia. In both 
CSI and sham-operated groups, the animals (5/time 
group) were allowed to recover for 4 h, 1, 2, 7 and 14 
days after the injury or sham operation. Another five 
age-matched intact animals was used as a physiologi-
cal control group.
Isolation of peripheral blood lymphocyte fraction
Lymphocytes were isolated from the rat blood col-
lected with heparin directly from heart and sepa-
rated on a density gradient as described by Böyum 
(1968). Lymphocytes were washed 3 times in saline 
and resuspended to a final concentration of 200 μg/
ml in saline. 
Trypan blue exclusion test of cell viability (TB test)
The TB test (Strober, 2001) was used to assess the 
viability of lymphocytes, and groups with viability 
greater than 95% were used for the experiments. Due 
to clear morphological distinctions, we determined 
the contamination of the samples with granulocytes 
and platelets and used the samples with less than 5% 
contamination in further experiments. 
Protein determination
Protein content was determined by the method de-
scribed by Bradford (1976), using bovine serum al-
bumin as standard.
Measurement of ATP, ADP and AMP hydrolysis in 
peripheral blood lymphocyte fraction
Freshly isolated lymphocytes were subjected to ATP-, 
ADP- and AMP-hydrolysis measurement according 
to Leal et al., (2005). The reaction medium contained 
0.5 mM CaCl2, 120 mM NaCl, 5 mM KCl, 60 mM 
glucose and 50 mM Tris-HCl buffer, pH 8.0, at a final 
volume of 200 μl. Twenty microliters (≈ 4 μg protein) 
of intact lymphocyte fraction was added to reaction 
medium and preincubated for 10 min at 37ºC. The 
reaction was started by the addition of ATP, ADP or 
AMP at a final concentration of 0.5 mM, incubation 
lasted for 60 min at 37ºC and then was stopped by 
adding 22 μl of 3M perchloric acid (PCA). Enzyme 
mixtures were chilled on ice for 10 min and then as-
sayed for inorganic phosphate (Pi) by the method de-
scribed by Chan et al. (1986), using malachite green 
as a colorimetric substrate and KH2PO4 as standard. 
All samples were assayed in quintuplicate, with con-
trols for every sample in order to correct for non-
enzymatic hydrolysis. The controls were prepared by 
adding substrate after PCA addition. Specific enzyme 
activities were reported as nmol Pi released/min/mg 
protein. 
Chemicals
All chemicals were purchased from Sigma Chemical 
Co. (St Louis, MO, USA), unless otherwise indicated.
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Data analysis
Results are expressed as means ± SEM. The compari-
son between time groups was made by Student’s t test 
for independent samples, followed by Tukey’s test for 
multiple comparisons among means. The signifi-
cance was determined at levels p < 0.05 (*), p < 0.005 
(**) and p < 0.001 (***). 
RESULTS
We analyzed nucleotide-hydrolyzing activities in the 
lymphocyte fractions obtained from animals sub-
mitted to CSI or sham operation at different post-
injury times and compared them to the activities of 
the intact control group (Fig. 1A-B, Fig.3). The intact 
group showed the highest hydrolyzing activity to-
wards ATP (9.2 ± 0.9 nmolPi/min/mg), less for ADP 
(6.7 ± 0.4 nmolPi/min/mg) and the lowest for AMP 
(5.9 ± 0.2 nmolPi/min/mg).
During the recovery period, the ATP hydrolyz-
ing activities in the CSI animals were significantly 
different in respect to the intact control group, but 
indistinguishable in comparison to the correspond-
ing sham group (Fig. 1A). ATP hydrolysis decreased 
at 4 h post-injury (72.5 ± 4.9%, p < 0.05) and dur-
ing the next several hours returned to the control 
levels. Afterwards, ATP hydrolysis significantly 
increased in both the injured and sham-operated 
groups in comparison to the intact control: at 2-day 
(136.6 ± 4.3% , p < 0.05) in CSI and (138.6 ± 1.2%, 
p < 0.05) in the sham-operated group, on day 7 (133.2 
± 5.2%, p < 0.05) in CSI and (124.8 ± 5.2%, p < 0.05) 
in the sham-operated group, at day 14 (151.5 ± 1.9%, 
p < 0.001) in CSI and (154.5 ± 7.9%, p < 0.05) in the 
sham-operated group.  
ADP hydrolysis in the CSI and corresponding 
sham-operated control groups followed a trend simi-
lar to that obtained for ATP hydrolysis (Fig. 1B). In 
both groups at 4 h ADP hydrolysis decreased slightly, 
but not significantly in respect to the intact control. 
At days 2 and 7, ADP hydrolysis both in the CSI and 
sham-operated groups was significantly higher in re-
spect to the intact control group: at day 2 (164.4 ± 
6.9%, p < 0.001) in CSI and (150.2 ± 6.6%, p < 0.005) 
in the sham-operated group, at day 7 (123.1 ± 1.7%, 
p < 0.005) in CSI and (142.5 ± 0.9%, p < 0.05) in 
the sham-operated group. At day 14, ADP hydrolysis 
in CSI returned to the intact control level, with the 
activities of the corresponding sham group still in-
creased in respect to the intact control (138.4± 1.9%, 
p < 0.05).
ATP/ADP hydrolysis ratios at different post-op-
erative times (Fig. 2), both for CSI and correspond-
ing sham groups, are calculated from the data given 
in Figs 1.A and B. Hydrolysis ratios both in the CSI 
and sham-operated groups were indistinguishable 
from the ratio obtained for the intact control group 
(1.4±0.2) throughout the observed period.
AMP hydrolysis (Fig. 3) at 4 h remained at the 
physiological level, both in the CSI and sham groups, 
while later in the CSI group the hydrolysis signifi-
cantly changed in comparison to the intact control 
group: at day 1 (170.9 ± 3.2%, p < 0.001), day 2 (126.4 
± 2.5%, p < 0.005), day 7 (175.0 ± 1.4%, p < 0.001) 
and day 14 (154.8 ± 7.7 %, p < 0.005), post-injury. 
In contrast to ATP and ADP hydrolysis, significant 
differences in respect to AMP hydrolysis occured be-
tween the CSI and sham-control animals: in CSI at 
day 2 (66.8 ± 2.15%, p < 0.001) and day 7 (146.2 ± 
3.14, p < 0.001) in comparison to the correspond-
ing sham group. For other time-points, the activities 
of the CSI animals were indistinguishable from the 
sham-operated group.
DISCUSSION
Our results clearly demonstrate that CSI induces 
significant and dynamic changes in adenine nu-
cleotide hydrolysis in the peripheral blood lym-
phocytes. ATP and ADP hydrolysis exhibited simi-
lar biphasic temporal profiles after the injury. In 
CSI animals, both hydrolyzing activities decreased 
at 4 h after the injury, while subsequently increasing 
relative to the intact control group during the rest 
of the recovery period. Another interesting finding 
was that both the CSI protocol that includes actual 
brain tissue damage and the sham-injury protocol 
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Fig. 1. ATP- (A) and ADP- (B) hydrolysis in peripheral blood lymphocyte fraction of rats at different times after CSI and sham opera-
tion. Samples were isolated from animals submitted to the CSI (dark bars) and sham operation (white bars) after 4-h, 1, 2, 7 and 14 
days and specific activity is represented as mean ± SEM. Dotted lines indicate the mean value of the respective activity in the peripheral 
blood lymphocyte fraction of intact control animals ± SEM (gray areas). Data are mean activities (nmol Pi/min/mg) from 2 independent 
determinations with 5 animals / group, assayed in quintuplicate and corrected for non-enzymatic hydrolysis. Different from the intact 
control animals: # p < 0.05, ## p < 0.005 and ### p < 0.001.
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that includes only an incision to the skin and thin 
membrane covering the skull bone, induced similar 
changes regarding ATP and ADP hydrolysis. This 
finding indicates that the changes in lymphocytic 
ATP and ADP hydrolysis were not induced by the 
brain injury itself, but might be the consequence 
of anesthesia or some other non-specific triggers 
present in both experimental groups. Yet another 
important finding regarding lymphocytic ATP and 
ADP hydrolysis was that their ratios were compara-
ble in CSI, sham-operated and intact control groups 
and remained unchanged throughout the recovery 
period. The ATP/ADP hydrolysis ratio of 1.4 ± 
0.2 (Kukulski et al., 2005) indicates E-NTPDase 1 
as the major contributing ectonucleotidase on the 
lymphocyte surface. 
Considering lymphocytic AMP hydrolysis, ac-
tivity was significantly increased during the whole 
recovery period, both in the CSI and sham groups in 
respect to intact animals. Since E-5NT is the major 
AMP hydrolyzing enzyme in the serum compart-
ment, this finding implies that brain injury and sham 
operation induce upregulation of E-5NT. However, it 
seems that the changes obtained for AMP hydrolysis 
were more brain-injury specific, since at days 2 and 
7 post-injury there were significant differences be-
tween the CSI and sham groups. Maximum E-5NT 
induction was observed at days 1 and 2 post-injury 
in the sham group, implying that the operation itself 
induced a transitory lymphocytic response, while 
CSI induced a sustained increase in E-5NT activ-
ity, implying that CSI induced a longer-lasting lym-
phocytic response. 
The obtained results suggest that CSI and sham 
operation induce upregulation of the whole enzyme 
chain for adenine nucleotide hydrolysis, namely 
NTPDase 1 and E-5NT. Only immediately after the 
injury was a decrease in ATP hydrolysis observed, 
suggesting decreased NTPDase 1 abundance on the 
lymphocyte surface. It was previously demonstrated 
Figure 2. ATP / ADP hydrolysis of peripheral blood lymphocyte fraction ratio at different times after CSI (dark bars) and sham opera-
tion (white bars). Ratios were calculated from the data given in Fig. 1. obtained for specific ATP- (A) and ADP- (B) hydrolyzing activities 
after 4 h, 1, 2, 7 and 14 days from sham operation(white bars) and CSI (dark bars). Dotted lines indicate the mean value of the ATP/ADP 
hydrolysis ratio obtained for the intact control group ±SEM (gray area).
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that shear stress induced the removal of the NTP-
Dase 1 enzyme protein from the surface of endothe-
lial cells (Yegutkin et al., 2000). In the light of previ-
ous findings, we speculate that the obtained decrease 
of NTPDase 1 activity might be caused by a rapid 
shedding of the enzyme protein from the lymphocyte 
surface.
The upregulations of E-NTPDase1 and E-5NT 
were previously observed in endothelial cells (Elt-
zschig et al. 2003) and B-lymphocytes (Coppola et 
al., 2005) after hypoxia, as well as in activated lym-
phocytes (Leal et al., 2005; Vuaden et al., 2007). 
Thus, we speculate that ischemic/hypoxic conditions 
induced by anesthesia and surgery as the immediate 
causes, induced the activation of lymphocytes that 
was evident through increased E-NTPDase1 and E-
5NT activities. The sustained increase in NTPDase 1 
and E-5NT after CSI and sham operation further im-
plies that both procedures lead to the accumulation 
of adenosine in the vascular compartment.
It should be noted, however, that ectonucleoti-
dases might have additional roles other than those 
related to nucleotide hydrolysis (Zimmermann 2000; 
2001). Ectonucleotidase shares substantial amino 
sequence homology and has a functional associa-
tion with cell adhesion molecules (Lin et al., 1991; 
Dzhandzhugazyan and Bock, 1997; Salmi and Jal-
kanen, 2005; 2012; Bours et al., 2011) involved in 
the processes of adhesion and recognition between 
different cell types. It was previously observed that 
E-5NT mediates lymphocyte binding to the vascular 
endothelium in inflamed human skin (Arvilommi et 
al., 1997). In addition, engagement of lymphocytic 
E-5NT was shown to induce an enhanced adhesion 
of lymphocytes to the endothelial cells through the 
clustering of lymphocyte function-associated an-
Figure 3. AMP hydrolysis in rat peripheral blood lymphocyte fraction at different times after CSI and sham operation. Samples were 
isolated from animals submitted to the CSI (dark bars) and sham operation (white bars) after 4 h, 1, 2, 7 and 14 days and specific activity 
is represented as mean ± SEM. Dotted lines indicate the mean value of the respective activity in the peripheral blood lymphocyte frac-
tion of intact control animals ± SEM (gray areas). Data are mean activities (nmol Pi/min/mg) from 2 independent determinations with 
5 animals/group, assayed in quintuplicate and corrected for non-enzymatic hydrolysis. Different from sham-operated animals, p < 0.001 
(***). Different from the intact control animals, # p < 0.05, ## p <0.005 and ### p < 0.001
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tigen 1 (LFA1, CD11a-CD18) (Airas et al., 2000). 
Consistent with reported findings was the observa-
tion that E-5NT expression is required for the entry 
of T lymphocytes into the CNS (Mills et al., 2008). 
Regarding NTPDase1, Kansas et al., (1991) showed 
that the binding of anti-NTPDase 1 mouse antibody 
to NTPDase 1 induces rapid and strong homotypic 
adhesion in various human B cell lines. Taken to-
gether, our findings suggest that E-5NT and NTP-
Dase 1, beside their enzymatic roles, might partici-
pate in lymphocytes adhesion and thereby contribute 
to the modulation of inflammatory processes after 
injury and sham operation.
In summary, our study shows that both brain 
injury and sham operation induce the upregulation 
of lymphocytic NTPDase 1 and E-5NT activities. 
The obtained changes suggest the activation of lym-
phocytes and modulation of effector cytokine pro-
duction. Modulation of the peripheral immune re-
sponse may further promote the progression of a sec-
ondary injury, thereby leading to the development of 
other neurological and non-neurological symptoms 
that frequently appear after brain injury. Therefore, 
changes in the adenine nucleotide metabolism in pe-
ripheral lymphocytes suggest that ectonucleotidases 
and purinergic signaling may have important roles 
in the course of recovery after brain injury. 
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